Bexsero®: First Vaccine to Prevent Meningococcal Serogroup B (MenB) Now Available in Canada

Bexsero®: First Vaccine to Prevent Meningococcal Serogroup B (MenB) Now Available in Canada

[CNW Group] – Bexsero®: First Vaccine to Prevent Meningococcal Serogroup B (MenB) Now Available in Canada more

View todays social media effects on NVS

View the latest stocks trending across Twitter. Click to view dashboard

See who Novartis is hiring next, click here to view

Share this post